FDA Clears Qvin Test that Uses Menstrual Blood
The clearance makes it possible for women who live with diabetes to receive monitoring of A1c, using laboratory tests performed on the Q-Pad.
Read MorePosted by Andy Lundin | Jan 8, 2024 | Diabetes & Metabolic Diseases, Womens Health |
The clearance makes it possible for women who live with diabetes to receive monitoring of A1c, using laboratory tests performed on the Q-Pad.
Read MorePosted by Andy Lundin | Jan 5, 2024 | Lung Cancer |
The diagnostic, which requires only a simple urine test to read the results, could make lung cancer screening more accessible worldwide.
Read MorePosted by Andy Lundin | Jan 5, 2024 | Molecular Diagnostics |
This collaboration relates to the development of Illumina’s MRD assay, a solution that detects ctDNA to understand the persistence of disease.
Read MorePosted by Andy Lundin | Jan 5, 2024 | Womens Health |
Researchers created a new screening test that uses a blood sample from an expectant mother to scrutinize all the genes in the fetus.
Read MorePosted by Andy Lundin | Jan 4, 2024 | Diagnostic Technologies |
The new biorepository can be instrumental in genetic and biomarker identification for patient populations with rapid disease progression.
Read More